1 Department of Radiology, Section of Interventional Radiology, Northwestern University, Chicago, Illinois. Electronic address: email@example.com.
2 Department of Radiology, Section of Interventional Radiology, Northwestern University, Chicago, Illinois.
3 Department of Surgery, Division of Surgical Oncology, University of Louisville, Louisville, Kentucky.
4 Vascular and Interventional Professionals, Hinsdale, Illinois.
5 Department of Radiology, Section of Interventional Radiology, Mount Sinai Hospital, New York, New York.
6 GetWellNetwork, Inc, Menlo Park, California.
7 (Formerly) HealthLoop, Inc, Mountain View, California; Division of Hospital Medicine, University of California San Francisco, San Francisco, California.
Health-related quality of life (HRQoL) measurements are important for patient care, and emerging bundles in value-based care are placing an increasing emphasis on tying reimbursement to patient surveys. A multicenter pilot study was carried out to assess the efficacy of an automated digital patient engagement (DPE) platform for collecting HRQoL measurements at baseline and at 2- to 4-week intervals through 90 days after transarterial radioembolization (TARE) with yttrium-90 (90Y) treatments for hepatocellular carcinoma (HCC). The results revealed a survey completion of 78.4% and demonstrated only 4 of 35 individual symptom instances across all time points of transient worsening relative to baseline. Most importantly, the DPE platform provided an effective means for deploying and collecting patient-reported outcome measures.